Generate Biomedicines, Inc. Common Stock (GENB)

$12.89 -2.16%

EARNINGS ANALYTICS

Generate Biomedicines, Inc. Common Stock (GENB) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -11.14% (May 07, 2026) and its biggest decline was -11.14% (May 07, 2026).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±11.14%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☀ PRE	$14.70	$14.91	$13.64	17,956	-11.14%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±11.14%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G

2 chevron_right

Recent SEC Filings

2 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov

Frequently asked about GENB earnings

How much does GENB stock move after earnings? expand_more

Over 1 reports, GENB has moved an average of ±11.14% the session after earnings, closing higher 0.0% of the time.

What was GENB's biggest post-earnings move? expand_more

GENB's largest post-earnings gain on record was -11.14% on May 07, 2026, and its largest decline was -11.14% on May 07, 2026.

Where can I find Generate Biomedicines, Inc. Common Stock's SEC filings? expand_more

All of Generate Biomedicines, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.